hrs-9813
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 24, 2024 (NCT06514963)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07229716 | Phase 1 | Nov 30, 2025 | Hengrui Therapeutics, Inc. |
| NCT07192939 | Phase 2 | Oct 31, 2025 | Hengrui Therapeutics, Inc. |
| NCT06939504 | Phase 1 | May 4, 2025 | Hengrui Therapeutics, Inc. |
| NCT06821464 | Phase 1 | Feb 28, 2025 | Hengrui Therapeutics, Inc. |
| NCT06514963 | Phase 1 | Jul 24, 2024 | Hengrui Therapeutics, Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 5 | 5 | 2 | 2024 |
1 organizations
Page 1 / 1